These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6577802)

  • 1. Carbamazepine in the treatment of bulimia.
    Kaplan AS; Garfinkel PE; Darby PL; Garner DM
    Am J Psychiatry; 1983 Sep; 140(9):1225-6. PubMed ID: 6577802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulimia treated with imipramine: a placebo-controlled, double-blind study.
    Pope HG; Hudson JI; Jonas JM; Yurgelun-Todd D
    Am J Psychiatry; 1983 May; 140(5):554-8. PubMed ID: 6342421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of Kleine-Levin syndrome stabilized for over 1 year with carbamazepine].
    Savet JF; Robert H; Angeli C
    Presse Med; 1986 Jul 5-12; 15(27):1281. PubMed ID: 2945184
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, placebo-controlled studies of bulimic patients.
    Rosebush P
    Am J Psychiatry; 1986 Sep; 143(9):1197-8. PubMed ID: 3529997
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of bulimia with antidepressants.
    Pope HG; Hudson JI
    Psychopharmacology (Berl); 1982; 78(2):176-9. PubMed ID: 6817375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind trial of phenelzine in bulimia.
    Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
    J Psychiatr Res; 1985; 19(2-3):485-9. PubMed ID: 3900362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bulimia with lithium.
    Hsu LK
    Am J Psychiatry; 1984 Oct; 141(10):1260-2. PubMed ID: 6435459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of bulimic symptoms with methylamphetamine.
    Ong YL; Checkley SA; Russell GF
    Br J Psychiatry; 1983 Sep; 143():288-93. PubMed ID: 6354341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium and bulimia: the role of the dopaminergic and opiatergic systems.
    Gillman MA; Lichtigfeld FJ
    Am J Psychiatry; 1985 Dec; 142(12):1522-3. PubMed ID: 3000202
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of bulimia with nomifensine.
    Pope HG; Herridge PL; Hudson JI; Fontaine R; Yurgelun-Todd D
    Am J Psychiatry; 1986 Mar; 143(3):371-3. PubMed ID: 3456724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin.
    Sabine EJ; Yonace A; Farrington AJ; Barratt KH; Wakeling A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):195S-202S. PubMed ID: 6337607
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of bulimia with monoamine oxidase inhibitors.
    Walsh BT; Stewart JW; Wright L; Harrison W; Roose SP; Glassman AH
    Am J Psychiatry; 1982 Dec; 139(12):1629-30. PubMed ID: 6959533
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid.
    Kennedy SH; Piran N; Garfinkel PE
    J Clin Psychopharmacol; 1985 Oct; 5(5):279-85. PubMed ID: 3862680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of L-tryptophan in treating bulimia.
    Krahn D; Mitchell J
    Am J Psychiatry; 1985 Sep; 142(9):1130. PubMed ID: 3895989
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of bulimia with nomifensine.
    Nassr DG
    Am J Psychiatry; 1986 Mar; 143(3):373-4. PubMed ID: 3456725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study.
    Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
    Arch Gen Psychiatry; 1984 Nov; 41(11):1105-9. PubMed ID: 6388524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAOIs in the treatment of bulimia.
    Fairburn CG; Cooper PJ
    Am J Psychiatry; 1983 Jul; 140(7):949-50. PubMed ID: 6574714
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1986 Apr; 143(4):519-22. PubMed ID: 3513634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the psychotropic effects of carbamazepine in manic-depressive illness mediated through the limbic system?
    Post RM; Uhde TW
    Psychiatr J Univ Ott; 1985 Dec; 10(4):205-19. PubMed ID: 3911236
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of eating by fenfluramine in patients with bulimia nervosa.
    Robinson PH; Checkley SA; Russell GF
    Br J Psychiatry; 1985 Feb; 146():169-76. PubMed ID: 3856458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.